Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
4.250
-0.040 (-0.93%)
At close: Sep 26, 2025, 4:00 PM EDT
4.370
+0.120 (2.82%)
After-hours: Sep 26, 2025, 7:49 PM EDT
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $163.97 million as of September 26, 2025. Its market cap has increased by 367.16% in one year.
Market Cap
163.97M
Enterprise Value
22.31M
1-Year Change
367.16%
Ranking
Category
Stock Price
$4.25
Market Cap Chart
Since October 22, 2014, Protara Therapeutics's market cap has increased from $140.90M to $163.97M, an increase of 16.38%. That is a compound annual growth rate of 1.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 164.00M | 50.60% |
| Dec 31, 2024 | 108.90M | 411.27% |
| Dec 29, 2023 | 21.30M | -29.47% |
| Dec 30, 2022 | 30.20M | -60.16% |
| Dec 31, 2021 | 75.80M | -72.07% |
| Dec 31, 2020 | 271.40M | 3,292.50% |
| Dec 31, 2019 | 8.00M | -81.65% |
| Dec 31, 2018 | 43.60M | 30.15% |
| Dec 29, 2017 | 33.50M | 6.35% |
| Dec 30, 2016 | 31.50M | -87.68% |
| Dec 31, 2015 | 255.70M | 49.44% |
| Dec 31, 2014 | 171.10M | 21.43% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 641.51B |
| Johnson & Johnson | 428.03B |
| AbbVie | 386.06B |
| UnitedHealth Group | 312.96B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 226.78B |